Newsroom Stories

A new study led by WashU Medicine researchers has found older-looking brains in adults with sickle cell disease, helping to explain the cognitive challenges experienced by such individuals.

Psychological researchers in Arts & Sciences find self-regulation and social engagement skills can potentially foster a sense of purpose.

As the 2025 legislative session kicks off, the Office of Government & Community Relations at Washington University in St. Louis has launched an advocacy program as well as an online map demonstrating WashU’s impact across the state.

A new and improved Mudd Field is coming to WashU in 2028. The space soon will be lined by shade trees and will feature a new “social green,” a shady retreat for students to swing on hammocks and relax between classes.

Flint Fowler, a strong champion for St. Louis’ young people and a WashU alumnus, will receive the annual Rosa L. Parks Award at the 38th annual Dr. Martin Luther King Jr. Commemoration at 2 p.m. Monday, Jan. 20. On the Medical Campus, Kemi Doll, MD, will discuss racial inequity in cancer care Friday, Jan. 24.

Sir Stephen Hough, a “keyboard colossus” (The Guardian) and “a pianist of great subtlety” (New York Times), will perform music of Cécile Chaminade, Franz Liszt and Frédéric Chopin for WashU’s Great Artists Series Feb. 2.

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.

Washington University researchers plan to use advanced math to better understand and control biological systems, specifically our body’s internal clock, possibly leading to better treatments for sleep-related issues.

A new study by Elizabeth Carlen, a postdoctoral fellow with the Living Earth Collaborative at WashU, outlines the ways by which city life may be shaping the evolution of urban coyotes, the highly adaptable carnivores spotted in alleyways from Berkeley, Calif., to the Bronx, in New York.

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.